But then it became a law of diminishing returns for the number of new compounds that could be effective. Being able to kill bacteria is not enough; you have to be able to make an antibiotic cheaply, and it has to be safe. So the number of really new compounds diminished and a lot of drug companies were modifying known antibiotics, trying to make them better and more effective